To examine the impact of TRIM37 on the progression of pancreatic cancer in vivo, we injected mouse pancreatic cancer cells containing shTRIM37 or shLacZ plasmid or WT into syngeneic mice. The gene discussed is TRIM37; the disease is familial pancreatic carcinoma.